BusinessMelinta Therapeutics’ Commercial Partner Eurofarma Laboratórios Submits Marketing Authorization Application for Delafloxacin in ArgentinaBy Nasdaq OMXFeb 20, 2018, 12:01 PM UTC
BusinessMelinta Therapeutics and Menarini Group Enter into Commercial and Co-Development Agreement for Delafloxacin in 68 CountriesBy Nasdaq OMXMar 2, 2017, 1:01 PM UTC
BusinessMelinta Therapeutics and Menarini Group Enter into Commercial and Co-Development Agreement for Delafloxacin in 68 CountriesBy Nasdaq OMXMar 2, 2017, 1:01 PM UTC
BusinessMelinta Therapeutics Initiates Phase 3 Study of Baxdela in Hospital-Treated Community-Acquired Bacterial PneumoniaBy Nasdaq OMXJan 6, 2016, 1:00 PM UTC
